Stryker Corporation $SYK Shares Bought by NBT Bank N A NY

Key Points

• NBT Bank N A NY increased its holdings in Stryker Corporation by 17.5% during Q2, owning 5,854 shares valued at approximately $2.32 million by the end of the reporting period.
• Stryker reported strong quarterly earnings, with $3.13 earnings per share exceeding analysts' estimates of $3.07, and a net revenue of $6.02 billion for the quarter.
• The company announced a quarterly dividend of $0.84 per share, with a yield of 0.9%, and has set its FY 2025 earnings guidance between 13.400 and 13.600 EPS.

NBT Bank N A NY grew its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 17.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,854 shares of the medical technology company's stock after purchasing an additional 870 shares during the period. NBT Bank N A NY's holdings in Stryker were worth $2,316,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Mogy Joel R Investment Counsel Inc. grew its holdings in shares of Stryker by 3.4% in the 1st quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock worth $36,561,000 after acquiring an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. grew its holdings in shares of Stryker by 1.9% in the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock worth $65,096,000 after acquiring an additional 3,341 shares during the period. Harbor Capital Advisors Inc. acquired a new stake in shares of Stryker in the 1st quarter worth approximately $1,840,000. Mar Vista Investment Partners LLC grew its holdings in shares of Stryker by 10.2% in the 1st quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company's stock worth $33,572,000 after acquiring an additional 8,353 shares during the period. Finally, United Services Automobile Association acquired a new stake in shares of Stryker in the 1st quarter worth approximately $2,857,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Stryker Trading Up 1.7%

Shares of Stryker stock opened at $375.35 on Thursday. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The firm has a market cap of $143.50 billion, a PE ratio of 49.72, a P/E/G ratio of 2.66 and a beta of 0.94. The business's fifty day moving average is $380.99 and its two-hundred day moving average is $378.83. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, topping analysts' consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. During the same quarter in the prior year, the company posted $2.81 EPS. The business's revenue for the quarter was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker's dividend payout ratio is currently 44.50%.

Wall Street Analysts Forecast Growth

SYK has been the topic of a number of research reports. Redburn Partners set a $420.00 price target on Stryker in a report on Thursday, September 18th. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Friday, September 26th. Wells Fargo & Company upped their price target on Stryker from $435.00 to $445.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Evercore ISI lowered their target price on Stryker from $418.00 to $410.00 and set an "outperform" rating on the stock in a report on Tuesday. Finally, Needham & Company LLC increased their target price on Stryker from $442.00 to $448.00 and gave the company a "buy" rating in a report on Friday, August 1st. Fifteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $430.10.

Insider Buying and Selling at Stryker

In related news, insider Viju Menon sold 500 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider directly owned 12,511 shares of the company's stock, valued at approximately $4,886,921.71. This trade represents a 3.84% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.